Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81–95 peptide show effective antitumor activity against ovarian carcinomaXiaoyan Zhang, Congjian Xu, Yu Kang et al.|International Journal of Pharmaceutics|2013Cited by 38
Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancerKe Li, Yu Kang|Cancer Immunology Immunotherapy|2022Cited by 24
SNX10 Is Involved in Ovarian Cancer Cell Metastasis by Repolarizing Tumor-Associated Macrophages Through mTOR1/Lysosomes PathwayRanran Chai, Yu Kang|Biomedicines|2025Cited by 2